Prognostic Factors in Periampullary Tumors and Cysts

Launched by UMEÅ UNIVERSITY · Nov 30, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on understanding factors that can predict how well patients with tumors or cysts in the pancreas or surrounding areas will respond to treatment. Researchers will look at both medical records and samples of blood and tissue to help identify important markers that could guide future treatment decisions. The goal is to improve diagnosis and surgical outcomes for patients with these conditions.

To participate, individuals should be recommended for surgery to remove a tumor or cyst in the pancreas or nearby regions. The trial is open to all genders and primarily targets adults aged 65 to 74. Participants will need to provide informed consent, meaning they agree to take part in the study and understand what it involves. If a patient is deceased, their information may still be used for part of the research. This study is currently recruiting participants, and those who join can expect to contribute to important research that may help improve treatment for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Recommended surgery for tumor or cyst in the pancreas or periampullary region
• • Information avalible in electronic journal files
• • Informed consent (or deceased for retrospective part of the study)
• Exclusion Criteria:
• • No informed consent (and still alive at study initiation)